Showing results (51-60 of 160) with videos related to

Sort By:
Pageof 16
Clinical Therapeutics|September 29, 2020
Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit-Risk Models: The Example of Rotavirus Vaccination in FranceHugo Arlegui, Gaëlle Nachbaur, Nicolas Praet, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 20, 2012
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1J Jaime Caro, Andrew H Briggs, Uwe Siebert, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1J Jaime Caro, Andrew H Briggs, Uwe Siebert, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 24, 2020
Leveraging DICE (Discretely-Integrated Condition Event) Simulation to Simplify the Design and Implementation of Hybrid ModelsJ Jaime Caro, Ross Maconachie, Michael Woods, et al.
International Psychogeriatrics|December 12, 2002
Describing cognitive decline of patients at the mild or moderate stages of Alzheimer's disease using the Standardized MMSEAlexandra Ward, J Jaime Caro, Heather Kelley, et al.
Plos One|August 20, 2021
Risk factors in adolescents as predictors of arterial hypertension in adults: Protocol for a systematic reviewMárcia Gisele Santos da Costa, J Jaime Caro, Katia Vergetti Bloch
BMC Health Services Research|September 4, 2003
Cost of managing an episode of relapse in multiple sclerosis in the United StatesJudith A O'Brien, Alexandra J Ward, Amanda R Patrick, et al.
Dementia and Geriatric Cognitive Disorders|July 30, 2002
Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the NetherlandsJ Jaime Caro, Maribel Salas, Alexandra Ward, et al.
The Journal of Clinical Ethics|May 21, 2011
Unaltered ethical standards for individual physicians in the face of drastically reduced resources resulting from an improvised nuclear device eventJ Jaime Caro, C Norman Coleman, Ann Knebel, et al.
Pharmacoeconomics|May 13, 2026
Comparison of Alternative Outcome Measures in Cost-Effectiveness Analysis: Three Applications Within OncologyBrian Reddy, Claire Telford, Apoorva Ambavane, et al.
Pageof 16